Brussels, 09/08/2004 (Agence Europe) - The European Commission on Monday refused to comment on rumours that it is considering taking action against the Anglo-Swedish pharmaceuticals company AstraZeneca. A Commission spokesperson simply repeated that the Commission would not confirm or comment. The Commission has examined alleged abuse of the patent system whereby AstraZeneca attempted to extend the time its ulcer drug, Losec, was protected.
According to the Financial Times, the competition...